Director, CMC Regulatory Affairs

GlaxoSmithKline (GSK) seeks an experienced, highly motivated professional to join our team as Director, CMC Regulatory Affairs. The successful candidate will lead GSK’s CMC Regulatory Affairs department and will ensure that GSK remains compliant with global regulatory requirements for CMC. This role requires an individual with a comprehensive knowledge of CMC strategies, regulations, and processes, as well as excellent leadership and communication skills. The ideal candidate will have a minimum of 10 years of experience in CMC Regulatory Affairs in the pharmaceutical or biotechnology industry, including a minimum of 5 years at a senior management level. A Bachelor's degree in Chemistry, Biochemistry, or a related field is required. A Master's degree is preferred. The successful candidate will possess exceptional problem-solving skills, be highly organized, and have the ability to effectively manage multiple projects and deadlines. The ideal candidate will also possess strong interpersonal skills, excellent written and verbal communication skills, and the ability to clearly communicate complex regulatory strategies. If you are a highly motivated and results-oriented professional with a passion for regulatory excellence, we would love to hear from you. Join us and be a part of a team that is dedicated to making a difference in the lives of people around the world.

According to JobzMall, the average salary range for a Director, CMC Regulatory Affairs in Collegeville, PA 19426, USA is between $155,000 and $220,000. The median salary for this position is $187,500. This salary range can vary depending on a variety of factors, such as experience, educational background, and the specific job duties.

GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.